The move from breast to blood born is questionable in some respects maybe it is the technology or maybe it's the commercial aspect the problem is it's not the first time it has looked like the later and if it is the case it probably will again. They always seem to move to an area that is the hot spot and all the rage with big pharma / big biotech but they also always late on the scene and stepping in a year after it was all frantic. By that time as PYC really aren't that fast moving compared to big companies potential partners are usually then all dealt out, projects advanced and onto the next big thing which PYC will probably catch up to the following year.
PYC Price at posting:
1.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)